A modified prognostic model in patients with diffuse large B-cell lymphoma treated with immunochemotherapy

In the era of immunochemotherapy, the traditional international prognostic index (IPI) has partially lost its predictive value in diffuse large B-cell lymphoma (DLBCL) and the National Comprehensive Cancer Network-IPI (NCCN-IPI) is unable to effectively identify high-risk patients. Thus, the present...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Peiqi, Zhu, Lei, Li, Lanfang, Zhou, Shiyong, Qiu, Lihua, Qian, Zhengzi, Xu, Wengui, Zhang, Huilai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856694/
https://www.ncbi.nlm.nih.gov/pubmed/33613707
http://dx.doi.org/10.3892/ol.2021.12479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856694/
https://www.ncbi.nlm.nih.gov/pubmed/33613707
http://dx.doi.org/10.3892/ol.2021.12479

Ejemplares similares